Using traditional SPECT systems, cardiac perfusion studies average about 15 to 20 minutes, limiting the amount of patients per day. With an "intelligent" Symbia IQ-SPECT imager, more patients can be scanned per day in much less time; as little as four minutes per patient for a full cardiac work-up.
Raising the bar even higher in well-established myocardial perfusion SPECT imaging evaluations is possible with hybrid Symbia SPECT/CT and IQ-SPECT. The addition of calcium scoring, extracted from a quick low-dose spiral CT scan that is also used to obtain attenuation correction information, is becoming a critical element in the cardiac work-up to screen patients for coronary artery disease (CAD). It can improve the risk stratification of patients who are at intermediate to high risk. Calcium scoring is an independent indicator of prognosis in CAD and in combination with SPECT, does improve diagnostic confidence.
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Adding the 30-second CT to the SPECT study can not only illustrate any ischemia present in the patient, but also can assess the buildup of calcium in the coronary arteries. Because many heart attacks occur in patients without obvious signs or risk factors, calcium scoring can definitively screen for and detect CAD. The addition of IQ-SPECT to SPECT/CT studies may lead to new risk stratification algorithms and work-ups for patients with suspected CAD.
*Works In Progress. The information about the product is preliminary. The product is under development and is not commercially available in the United States, and its future availability cannot be ensured.
**New product feature based on preliminary internal data. Actual performance characteristics have not been established.
Also at the SNM meeting, Siemens honored the early adapters of its innovative high-definition positron emission tomography (HD-PET) technology at their booth.
Siemens' HD-PET is the world's first and only high-definition PET technology to offer consistently sharper and clearly defined images across the entire field of view. The clarity achieved by HD-PET is the result of a unique and proprietary technology that optimizes the elements of image uniformity, resolution and contrast - that together change the whole picture.
"Our Biograph 64 has enabled our hospital to image 49 patients in a single day, and our monthly record is 764 patients," said Xu Zhensheng, director of Shanghai Fudan University affiliated Huashan Hospital PET center in Shanghai, China.
About Siemens Healthcare
Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.
Back to HCB News
